Dabigatran versus Warfarin in Patients with Mechanical Heart ValvesJohn W. Eikelboom, Frans Van de Werf, Jeffrey Friedman et al.|New England Journal of Medicine|2013Cited by 1.5k
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trialAdriaan A. Voors, Piotr Ponikowski, Christiane E. Angermann et al.|Nature Medicine|2022Cited by 889
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trialJan Biegus, Piotr Ponikowski, Adriaan A. Voors et al.|European Heart Journal|2022Cited by 213
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE TrialMikhail Kosiborod, Adriaan A. Voors, Christiane E. Angermann et al.|Circulation|2022Cited by 142